135 related articles for article (PubMed ID: 1190837)
1. The measurement of corticosteroid induced dermal atrophy by a radiological method.
Marks R; Dykes PJ; Roberts E
Arch Dermatol Res (1975); 1975 Sep; 253(2):93-6. PubMed ID: 1190837
[TBL] [Abstract][Full Text] [Related]
2. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for using superpotent topical steroids.
Prawer SE; Katz HI
Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
[TBL] [Abstract][Full Text] [Related]
4. Proceedings: Measurement of dermal atrophy induced by topical steroids using a radiographic technique.
James MP; Black MM; Sparkes CG
Br J Dermatol; 1976 Jul; 95 Suppl 14():12. PubMed ID: 1276038
[No Abstract] [Full Text] [Related]
5. Measurement of skin thickness: a comparison of two in vivo techniques with a conventional histometric method.
Dykes PJ; Marks R
J Invest Dermatol; 1977 Sep; 69(3):275-8. PubMed ID: 894062
[TBL] [Abstract][Full Text] [Related]
6. Femoral head osteonecrosis after topical corticosteroid therapy.
el Maghraoui A; Tabache F; Bezza A; Ghafir D; Ohayon V; Archane MI
Clin Exp Rheumatol; 2001; 19(2):233. PubMed ID: 11326500
[No Abstract] [Full Text] [Related]
7. [Pseudoatrophic pityriasis versicolor].
Mazuecos Blanca J; García-Bravo B; Moreno Giménez JC; Sotillo I; Camacho F
Med Cutan Ibero Lat Am; 1990; 18(2):101-3. PubMed ID: 2214935
[TBL] [Abstract][Full Text] [Related]
8. Hiccups with betamethasone dipropionate.
MacGregor EG; Villalobos R; Perini L
J Rheumatol; 2000 Mar; 27(3):819-20. PubMed ID: 10743834
[No Abstract] [Full Text] [Related]
9. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.
Fleischer AB; Feldman SR
Clin Ther; 1999 Oct; 21(10):1725-31. PubMed ID: 10566568
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic Cushing's syndrome in a dog from owner's topical corticosteroid.
Ridgway HB; Moriello KA
Arch Dermatol; 1993 Mar; 129(3):379. PubMed ID: 8447682
[No Abstract] [Full Text] [Related]
11. Persistent hiccups associated with intraarticular corticosteroid injection.
Gutierrez-Ureña S; Ramos-Remus C
J Rheumatol; 1999 Mar; 26(3):760. PubMed ID: 10090205
[No Abstract] [Full Text] [Related]
12. Facial blanching caused by superpotent corticosteroids.
Hessel A; Zyniewicz K
Cutis; 1991 Nov; 48(5):395. PubMed ID: 1837262
[TBL] [Abstract][Full Text] [Related]
13. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
Marks R
Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
[TBL] [Abstract][Full Text] [Related]
14. Majocchi's granuloma (due to therapy with steroid and occlusion).
Jacobs PH
Cutis; 1986 Jul; 38(1):23. PubMed ID: 3731863
[No Abstract] [Full Text] [Related]
15. [Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate].
Schuppli R; Dressler H; Yawalkar SJ; Weirich EG
Z Hautkr; 1983 Feb; 58(4):230-7. PubMed ID: 6342285
[TBL] [Abstract][Full Text] [Related]
16. Crusted (Norwegian) scabies induced by use of topical corticosteroids and treated successfully with ivermectin.
Marlière V; Roul S; Labrèze C; Taïeb A
J Pediatr; 1999 Jul; 135(1):122-4. PubMed ID: 10393619
[TBL] [Abstract][Full Text] [Related]
17. Dose-response effects of tri-iodothyroacetic acid (Triac) and other thyroid hormone analogues on glucocorticoid-induced skin atrophy in the haired mouse.
Faergemann J; Särnhult T; Hedner E; Carlsson B; Lavin T; Zhao XH; Sun XY
Acta Derm Venereol; 2002; 82(3):179-83. PubMed ID: 12353707
[TBL] [Abstract][Full Text] [Related]
18. Atrophy of the skin. The clinical problems.
Sneddon IB
Br J Dermatol; 1976 Mar; 94 suppl 12():121-3. PubMed ID: 1268072
[No Abstract] [Full Text] [Related]
19. Adrenal insufficiency and diabetes mellitus secondary to the use of topical corticosteroids for cosmetic purpose.
Sobngwi E; Lubin V; Ury P; Timsit FJ; Gautier JF; Vexiau P
Ann Endocrinol (Paris); 2003 Jun; 64(3):202-4. PubMed ID: 12910062
[TBL] [Abstract][Full Text] [Related]
20. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
